Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Alexander Lin, M.D., is Associate Professor in the Department of Radiation Oncology at the Perelman School of Medicine, and the Medical Director of the Roberts Proton Therapy Center at the University of Pennsylvania. Dr. Lin leads research programs in personalized approaches in the multidisciplinary treatment of head and neck cancer. Dr. Lin leads studies in novel methods of toxicity mitigation in patients with Human Papillomavirus (HPV)-associated cancers of the oropharynx. He also specializes in clinical trials investigating new radiosensitizing agents targeting the tumor microenvironment to improve disease outcomes, for which he receives funding from the National Cancer Institute (NCI) and National Institutes of Health (NIH). Dr. Lin completed his undergraduate studies at Yale University and his medical training at the University of Michigan. He is a board-certified radiation oncologist and practicing physician at the University of Pennsylvania, Perelman School of Medicine.
Grewal AS, Rajasekaran K, Cannady SB, Chalian AA, Ghiam AF, Lin A, LiVolsi V, Lukens JN, Mitra N, Montone KT, Newman JG, O’Malley Jr. BW, Rassekh CH, Weinstein GS, Swisher-McClure S: Pharyngeal Sparing Radiation for Head and Neck Carcinoma of Unknown Primary following TORS work-up The Laryngoscope 130 (3): 691-697,2020.
Swisher-McClure S, Lukens JN, Aggarwal C, Ahn P, Basu D, Bauml JM, Brody R, Chalian A, Cohen RB, Fotouhi-Ghiam A, Geiger G, Gershowitz J, Livolsi V, Mick R, Mitra N, Montone K, Newman J, Ojerholm E, O’Malley Jr. B, Rajasekeran K, Tan E, Weinstein G, Lin A: A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification: Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx International Journal of Radiation Oncology, Biology, Physics 106 (4): 725-732,2020.
Hague C, Aznar MC, Li T, O’Reilly S, Dong L, Fotouhi-Ghiam A, Lee LW, Lowe M, Lukens JN, McPartlin A, Slevin N, Swisher-McClure S, Thomson D, van Herk M, West C, Zou W, Lin A, Teo BK.: Inter-fraction Robustness of Intensity-Modulated Proton Therapy in the Post-operative Treatment of Oropharyngeal and Oral Cavity Squamous Cell Carcinomas British Journal of Radiology 93 (1107): 20190638,2020.
Diffenderfer ES, Kim MM, Verginadi II, Shoniyozov K, Hagan S, Avery S, Teo K, Zou W, Lin A, Swisher-McClure S, Koch C, Kennedy AR, Maity A, Busch TM, Dong L, Koumenis C, Metz J, Cengel KA: Design, Implementation and In Vivo Validation of a Novel Proton FLASH Radiotherapy System International Journal of Radiation Oncology, Biology, Physics 106 (2): 440-448,2020.
Chao HH, Schonewolf C, Tan E, Swisher-McClure SS, Ghiam AF, Weinstein GS, O’Malley Jr BW, Chalian AA, Rassekh CH, Newman JG, Cohen RB, Bauml JM, Aggarwal C, Lin A*, Lukens JN*: The Impact of Treatment Package Time on Locoregional Control for HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Surgery and Postoperative (Chemo)Radiation Head and Neck 41 (11): 3858-3868,2019.
Gershowitz J, Chao HH, Doucette A, Lukens JN, Swisher-McClure S, Weinstein GS, O’Malley Jr BW, Chalian AA, Rassekh CH, Newman JG, Cohen RB, Bauml JM, Aggarwal C, Lin A: Risk of Post-Operative, Pre-Radiotherapy Contralateral Neck Recurrence in Patients Treated with Surgery Followed by Adjuvant Radiotherapy for Human Papilloma Virus-Associated Tonsil Cancer British Journal of Radiology 92 : 20190466,2019.
Men K, Geng H, Zhong H, Fan Y, Lin A, Xiao Y: A deep learning model for predicting xerostomia due to radiotherapy
for head-and-neck squamous cell carcinoma in the RTOG 0522
clinical trial International Journal of Radiation Oncology, Biology, Physics 105 (2): 440-447,2019.
Grewal A, Jones J, Lin A: Palliative radiation therapy for head and neck cancers International Journal of Radiation Oncology, Biology, Physics 105 (2): 254-266,2019.
Baumann B, Lustig R, Mazzoni S, Grady MS, O'Malley Jr. B, Lee J, Newman J, Schuster J, Both S, Lin A, Dorsey J, Alonso-Basanta M: A Prospective Clinical Trial of Proton Therapy for Chordoma and Chondrosarcoma: Feasibility Assessment Journal of Surgical Oncology 120 (2): 200-205,2019.
Rwigema JM, Langendijk JA, van der Laan HP, Lukens JN, Swisher-McClure SD, Lin A: A model-based approach to predict short-term toxicity benefits with proton therapy for oropharyngeal cancer International Journal of Radiation Oncology, Biology, Physics 104 (3): 553-562,2019.
University of PennsylvaniaDepartment of Radiation Oncology3400 Civic Center BlvdTRC 2 West
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.